Gemfibrozil attenuates doxorubicin induced toxicity in renal tissues of male rats by reducing the oxidative insult and inflammation. (2nd October 2020)

• Record Type: Journal Article
• Authors: Hosseinzadeh, Azam; Goudarzi, Mehdi; Fatemi, Iman; Khodayar, Mohammad Javad; Mehrzadi, Saeed; Khalili, Hamid Reza; Karimi, Mohammad Ali
• Is Part Of: Biotechnic & histochemistry. Volume 95:Number 7(2020)
• Page Start: 532
• Page End: 539
• Publication Date: 2020-10-02
• Subjects: doxorubicin -- gemfibrozil -- inflammation -- kidney -- nephrotoxicity -- oxidative stress -- rat; Histochemistry -- Periodicals; Stains and staining (Microscopy) -- Periodicals; Biotechnology -- Periodicals; 572
• DOI: 10.1080/10520295.2020.1730967
• Languages: English
• ISSNs: 1052-0295

Abstract

ABSTRACT: Nephrotoxicity is a significant side effect of doxorubicin (DXN) treatment. We investigated the protective effect of gemfibrozil (GEM) co-administration with DXN on DXN induced nephrotoxicity. We divided 28 male Wistar rats into four groups of seven. Group 1 received normal saline for 2 weeks. Group 2 received 15 mg/kg DXN for 2 weeks. Group 3 received DXN + GEM for 2 weeks. Group 4 received GEM for 2 weeks. On day 15 of the experiment, blood samples were collected, animals were sacrificed and kidneys were excised for biochemical and histological evaluation. We measured serum creatinine, blood urine nitrogen, renal malondialdehyde, nitric oxide, glutathione, superoxide dismutase, glutathione peroxidase, catalase, tumor necrosis factor-α and interleukin-1β. GEM administration mitigated DXN induced nephrotoxicity. GEM co-administered with DXN attenuated the inflammatory and oxidative responses associated with DXN induced nephrotoxicity.